V.V Chekrysheva(North-Caucasus Zonal Scientific Research Veterinary Institute - Branch of the Federal State Budget Scientific Institution, Federal Rostov Agricultural Research Centre, RUSSIA),
I.A. Rodin (Department of Anatomy, Veterinary Obstetrics and Surgery, Kuban State Agrarian University, Krasnodar, RUSSIA).
Disciplinary: Veterinary Science.
➤ FullText
DOI: 10.14456/ITJEMAST.2020.187
Keywords: Sick cats; Female cats; Breast pathology; Mammary gland; Purulent form of mastitis; Ill cats; Hematological parameters; Inflammation.
Abstract
A comparative analysis of the most common methods of treating mastitis in cats is carried out, and the incidence of mastitis in cats among the entire obstetric and gynecological pathology is studied. Currently, mastitis in cats is an urgent problem, due to the high cost of treatment costs, the possible death of the cat itself, as well as the shortage of litter of nutrients due to the lack of milk in the female. Possible complications after cats are ill with a purulent form of mastitis include a lack of lactation. Thus, the problem of finding rational methods for treating purulent forms of mastitis in cats is relevant not only for veterinarians but also for owners of animals. Mastitis is the most common pathology among cats and makes up 36.5%. In the course of studies, it was revealed that the purulent form of mastitis occurs in 41% of rays among all forms of mastitis in cats. The clinical picture with a purulent form of mastitis is pronounced: the animal is depressed, refuses to eat, body temperature is increased to 40?C, and pulse and respiratory rate are increased. Signs of inflammation in the mammary gland are also pronounced. The mammary gland is enlarged, hot, hyperemic, swollen, soreness pronounced. A secretion of pus is secreted from the nipples with an unpleasant odor of white-yellow color. Also during the operation was investigated for therapeutic efficacy ?omplex schemes s treatment using antibiotic Sinuloks and non-steroidal anti-inflammatory drug Ainil. The therapeutic efficacy of this regimen reaches 100% within 5 days. A comprehensive treatment regimen using m antibacterial drug Kobactan 2.5% and non-steroidal anti-inflammatory drug Meloxivet 2% is therapeutically effective in 100% of cases for 5 days. The animals of the control group used the antibacterial drug Bicillin 3 twice. Such therapy showed very low therapeutic efficacy (40%).
Paper ID: 11A10D
Cite this article:
Chekrysheva, V.V., Rodin, I.A. (2020). THERAPIES OF PURULENT MASTITIS IN CATS. International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies, 11(10), 11A10D, 1-7.